Review



enzyme linked immunosorbent assay kit  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    R&D Systems enzyme linked immunosorbent assay kit
    Enzyme Linked Immunosorbent Assay Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 52 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/enzyme linked immunosorbent assay kit/product/R&D Systems
    Average 94 stars, based on 52 article reviews
    enzyme linked immunosorbent assay kit - by Bioz Stars, 2026-05
    94/100 stars

    Images



    Similar Products

    pe antihuman cd163  (Multi Sciences (Lianke) Biotech Co Ltd)
    93
    Multi Sciences (Lianke) Biotech Co Ltd pe antihuman cd163
    Pe Antihuman Cd163, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pe antihuman cd163/product/Multi Sciences (Lianke) Biotech Co Ltd
    Average 93 stars, based on 1 article reviews
    pe antihuman cd163 - by Bioz Stars, 2026-05
    93/100 stars
    		  Buy from Supplier
    cd163 microbead kit  (Miltenyi Biotec)
    94
    Miltenyi Biotec cd163 microbead kit
    Senescence-like TAMs in clinical specimens. (A) IF analysis of p16 + <t>CD163</t> + TAMs in treatment-naïve TNBC (direct surgery, n = 20) versus post-neoadjuvant chemotherapy specimens ( n = 17). (B) IF analysis of p16 + CD163 + TAMs in post-chemotherapy samples from patients with progressive disease (PD, n = 5) versus complete/partial remission (CR/PR, n = 12). (C) The senescence-like TAM gene signature scores across different sample groups: complete response, partial response, stable disease, and progressive disease. Data was from the BRCA-TCGA cohort and analyzed by GEPIA3 ( https://gepia3.bioinfoliu.com/ ). (D) The prognostic value of senescence-like TAM gene signature in cases with Carboplatin treatment. For statistical analyses, an unpaired two-tailed t-test (A and B) or log-rank test (E) was used. ** P < 0.01 and **** P < 0.0001
    Cd163 Microbead Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd163 microbead kit/product/Miltenyi Biotec
    Average 94 stars, based on 1 article reviews
    cd163 microbead kit - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    anti cd163 antibody  (Bio-Rad)
    94
    Bio-Rad anti cd163 antibody
    Senescence-like TAMs in clinical specimens. (A) IF analysis of p16 + <t>CD163</t> + TAMs in treatment-naïve TNBC (direct surgery, n = 20) versus post-neoadjuvant chemotherapy specimens ( n = 17). (B) IF analysis of p16 + CD163 + TAMs in post-chemotherapy samples from patients with progressive disease (PD, n = 5) versus complete/partial remission (CR/PR, n = 12). (C) The senescence-like TAM gene signature scores across different sample groups: complete response, partial response, stable disease, and progressive disease. Data was from the BRCA-TCGA cohort and analyzed by GEPIA3 ( https://gepia3.bioinfoliu.com/ ). (D) The prognostic value of senescence-like TAM gene signature in cases with Carboplatin treatment. For statistical analyses, an unpaired two-tailed t-test (A and B) or log-rank test (E) was used. ** P < 0.01 and **** P < 0.0001
    Anti Cd163 Antibody, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd163 antibody/product/Bio-Rad
    Average 94 stars, based on 1 article reviews
    anti cd163 antibody - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    blocking solution  (Bio-Rad)
    94
    Bio-Rad blocking solution
    Senescence-like TAMs in clinical specimens. (A) IF analysis of p16 + <t>CD163</t> + TAMs in treatment-naïve TNBC (direct surgery, n = 20) versus post-neoadjuvant chemotherapy specimens ( n = 17). (B) IF analysis of p16 + CD163 + TAMs in post-chemotherapy samples from patients with progressive disease (PD, n = 5) versus complete/partial remission (CR/PR, n = 12). (C) The senescence-like TAM gene signature scores across different sample groups: complete response, partial response, stable disease, and progressive disease. Data was from the BRCA-TCGA cohort and analyzed by GEPIA3 ( https://gepia3.bioinfoliu.com/ ). (D) The prognostic value of senescence-like TAM gene signature in cases with Carboplatin treatment. For statistical analyses, an unpaired two-tailed t-test (A and B) or log-rank test (E) was used. ** P < 0.01 and **** P < 0.0001
    Blocking Solution, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/blocking solution/product/Bio-Rad
    Average 94 stars, based on 1 article reviews
    blocking solution - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    datasheet mca1853  (Bio-Rad)
    94
    Bio-Rad datasheet mca1853
    Senescence-like TAMs in clinical specimens. (A) IF analysis of p16 + <t>CD163</t> + TAMs in treatment-naïve TNBC (direct surgery, n = 20) versus post-neoadjuvant chemotherapy specimens ( n = 17). (B) IF analysis of p16 + CD163 + TAMs in post-chemotherapy samples from patients with progressive disease (PD, n = 5) versus complete/partial remission (CR/PR, n = 12). (C) The senescence-like TAM gene signature scores across different sample groups: complete response, partial response, stable disease, and progressive disease. Data was from the BRCA-TCGA cohort and analyzed by GEPIA3 ( https://gepia3.bioinfoliu.com/ ). (D) The prognostic value of senescence-like TAM gene signature in cases with Carboplatin treatment. For statistical analyses, an unpaired two-tailed t-test (A and B) or log-rank test (E) was used. ** P < 0.01 and **** P < 0.0001
    Datasheet Mca1853, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/datasheet mca1853/product/Bio-Rad
    Average 94 stars, based on 1 article reviews
    datasheet mca1853 - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    anti cd163  (Bio-Rad)
    94
    Bio-Rad anti cd163
    Senescence-like TAMs in clinical specimens. (A) IF analysis of p16 + <t>CD163</t> + TAMs in treatment-naïve TNBC (direct surgery, n = 20) versus post-neoadjuvant chemotherapy specimens ( n = 17). (B) IF analysis of p16 + CD163 + TAMs in post-chemotherapy samples from patients with progressive disease (PD, n = 5) versus complete/partial remission (CR/PR, n = 12). (C) The senescence-like TAM gene signature scores across different sample groups: complete response, partial response, stable disease, and progressive disease. Data was from the BRCA-TCGA cohort and analyzed by GEPIA3 ( https://gepia3.bioinfoliu.com/ ). (D) The prognostic value of senescence-like TAM gene signature in cases with Carboplatin treatment. For statistical analyses, an unpaired two-tailed t-test (A and B) or log-rank test (E) was used. ** P < 0.01 and **** P < 0.0001
    Anti Cd163, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd163/product/Bio-Rad
    Average 94 stars, based on 1 article reviews
    anti cd163 - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    protein isoforms  (Bio-Rad)
    94
    Bio-Rad protein isoforms
    Senescence-like TAMs in clinical specimens. (A) IF analysis of p16 + <t>CD163</t> + TAMs in treatment-naïve TNBC (direct surgery, n = 20) versus post-neoadjuvant chemotherapy specimens ( n = 17). (B) IF analysis of p16 + CD163 + TAMs in post-chemotherapy samples from patients with progressive disease (PD, n = 5) versus complete/partial remission (CR/PR, n = 12). (C) The senescence-like TAM gene signature scores across different sample groups: complete response, partial response, stable disease, and progressive disease. Data was from the BRCA-TCGA cohort and analyzed by GEPIA3 ( https://gepia3.bioinfoliu.com/ ). (D) The prognostic value of senescence-like TAM gene signature in cases with Carboplatin treatment. For statistical analyses, an unpaired two-tailed t-test (A and B) or log-rank test (E) was used. ** P < 0.01 and **** P < 0.0001
    Protein Isoforms, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/protein isoforms/product/Bio-Rad
    Average 94 stars, based on 1 article reviews
    protein isoforms - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    enzyme linked immunosorbent assay kit  (R&D Systems)
    94
    R&D Systems enzyme linked immunosorbent assay kit
    Senescence-like TAMs in clinical specimens. (A) IF analysis of p16 + <t>CD163</t> + TAMs in treatment-naïve TNBC (direct surgery, n = 20) versus post-neoadjuvant chemotherapy specimens ( n = 17). (B) IF analysis of p16 + CD163 + TAMs in post-chemotherapy samples from patients with progressive disease (PD, n = 5) versus complete/partial remission (CR/PR, n = 12). (C) The senescence-like TAM gene signature scores across different sample groups: complete response, partial response, stable disease, and progressive disease. Data was from the BRCA-TCGA cohort and analyzed by GEPIA3 ( https://gepia3.bioinfoliu.com/ ). (D) The prognostic value of senescence-like TAM gene signature in cases with Carboplatin treatment. For statistical analyses, an unpaired two-tailed t-test (A and B) or log-rank test (E) was used. ** P < 0.01 and **** P < 0.0001
    Enzyme Linked Immunosorbent Assay Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/enzyme linked immunosorbent assay kit/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    enzyme linked immunosorbent assay kit - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    human soluble cd163 kit  (Cusabio)
    93
    Cusabio human soluble cd163 kit
    Senescence-like TAMs in clinical specimens. (A) IF analysis of p16 + <t>CD163</t> + TAMs in treatment-naïve TNBC (direct surgery, n = 20) versus post-neoadjuvant chemotherapy specimens ( n = 17). (B) IF analysis of p16 + CD163 + TAMs in post-chemotherapy samples from patients with progressive disease (PD, n = 5) versus complete/partial remission (CR/PR, n = 12). (C) The senescence-like TAM gene signature scores across different sample groups: complete response, partial response, stable disease, and progressive disease. Data was from the BRCA-TCGA cohort and analyzed by GEPIA3 ( https://gepia3.bioinfoliu.com/ ). (D) The prognostic value of senescence-like TAM gene signature in cases with Carboplatin treatment. For statistical analyses, an unpaired two-tailed t-test (A and B) or log-rank test (E) was used. ** P < 0.01 and **** P < 0.0001
    Human Soluble Cd163 Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human soluble cd163 kit/product/Cusabio
    Average 93 stars, based on 1 article reviews
    human soluble cd163 kit - by Bioz Stars, 2026-05
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    Senescence-like TAMs in clinical specimens. (A) IF analysis of p16 + CD163 + TAMs in treatment-naïve TNBC (direct surgery, n = 20) versus post-neoadjuvant chemotherapy specimens ( n = 17). (B) IF analysis of p16 + CD163 + TAMs in post-chemotherapy samples from patients with progressive disease (PD, n = 5) versus complete/partial remission (CR/PR, n = 12). (C) The senescence-like TAM gene signature scores across different sample groups: complete response, partial response, stable disease, and progressive disease. Data was from the BRCA-TCGA cohort and analyzed by GEPIA3 ( https://gepia3.bioinfoliu.com/ ). (D) The prognostic value of senescence-like TAM gene signature in cases with Carboplatin treatment. For statistical analyses, an unpaired two-tailed t-test (A and B) or log-rank test (E) was used. ** P < 0.01 and **** P < 0.0001

    Journal: Cellular Oncology

    Article Title: Targeting senescence-like tumor-associated macrophages sensitizes chemotherapy in triple-negative breast cancer

    doi: 10.1007/s13402-026-01197-3

    Figure Lengend Snippet: Senescence-like TAMs in clinical specimens. (A) IF analysis of p16 + CD163 + TAMs in treatment-naïve TNBC (direct surgery, n = 20) versus post-neoadjuvant chemotherapy specimens ( n = 17). (B) IF analysis of p16 + CD163 + TAMs in post-chemotherapy samples from patients with progressive disease (PD, n = 5) versus complete/partial remission (CR/PR, n = 12). (C) The senescence-like TAM gene signature scores across different sample groups: complete response, partial response, stable disease, and progressive disease. Data was from the BRCA-TCGA cohort and analyzed by GEPIA3 ( https://gepia3.bioinfoliu.com/ ). (D) The prognostic value of senescence-like TAM gene signature in cases with Carboplatin treatment. For statistical analyses, an unpaired two-tailed t-test (A and B) or log-rank test (E) was used. ** P < 0.01 and **** P < 0.0001

    Article Snippet: Endothelial cells were enriched by magnetic-activated cell sorting using the CD31 MicroBead Kit (Miltenyi Biotec Cat# 130-091-935, RRID: AB_3699142), TAMs were enriched with the CD163 MicroBead Kit (Miltenyi Biotec, Cat# 130-124-420), and CAFs were enriched using Anti-Fibroblast MicroBeads (Miltenyi Biotec, Cat# 130-050-601), in accordance with the manufacturers’ protocols.

    Techniques: Two Tailed Test